Literature DB >> 16154874

Neuromuscular control of the point to point and oscillatory movements of a sagittal arm with the actor-critic reinforcement learning method.

Vahid Golkhou1, Mohamad Parnianpour, Caro Lucas.   

Abstract

In this study, we have used a single link system with a pair of muscles that are excited with alpha and gamma signals to achieve both point to point and oscillatory movements with variable amplitude and frequency.The system is highly nonlinear in all its physical and physiological attributes. The major physiological characteristics of this system are simultaneous activation of a pair of nonlinear muscle-like-actuators for control purposes, existence of nonlinear spindle-like sensors and Golgi tendon organ-like sensor, actions of gravity and external loading. Transmission delays are included in the afferent and efferent neural paths to account for a more accurate representation of the reflex loops.A reinforcement learning method with an actor-critic (AC) architecture instead of middle and low level of central nervous system (CNS), is used to track a desired trajectory. The actor in this structure is a two layer feedforward neural network and the critic is a model of the cerebellum. The critic is trained by state-action-reward-state-action (SARSA) method. The critic will train the actor by supervisory learning based on the prior experiences. Simulation studies of oscillatory movements based on the proposed algorithm demonstrate excellent tracking capability and after 280 epochs the RMS error for position and velocity profiles were 0.02, 0.04 rad and rad/s, respectively.

Entities:  

Mesh:

Year:  2005        PMID: 16154874     DOI: 10.1080/10255840500167952

Source DB:  PubMed          Journal:  Comput Methods Biomech Biomed Engin        ISSN: 1025-5842            Impact factor:   1.763


  1 in total

1.  Characterizing Motor Control of Mastication With Soft Actor-Critic.

Authors:  Amir H Abdi; Benedikt Sagl; Venkata P Srungarapu; Ian Stavness; Eitan Prisman; Purang Abolmaesumi; Sidney Fels
Journal:  Front Hum Neurosci       Date:  2020-05-26       Impact factor: 3.169

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.